Evofem Biosciences (EVFM) Misses Q4 EPS by 3c

Evofem Biosciences (OTC: EVFM) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $7.1 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• RBC Capital Starts Revvity Inc (RVTY) at Sector Perform
• Z AI Co Ltd (2513:HK) PT Raised to HK$1,500 at Bernstein SocGen Group